Summary The effect of charge modification of photoimmunoconjugates (PICs) on their biodistribution in a xenograft model of ovarian cancer was investigated. Chlorin.6 e6 was attached site specifically to the F(ab')2 fragment of the murine monoclonal antibody OC125, directed against human ovarian cancer cells, via poly-1-lysine linkers carrying cationic or anionic charges. Preservation of immunoreactivity was checked by enzyme-linked immunosorbent assay (ELISA). PICs were radiolabelled with 1251 and compared with non-specific rabbit IgG PICs after intraperitoneal (i.p.) injection into nude mice. Samples were taken from normal organs and tumour at 3 h and 24 h. Tumour to normal 1251 ratios showed that the cationic OC1 25F(ab')2 PIC had the highest tumour selectivity. Ratios for ce6 were uniformly higher than for 1251, indicating that ce6 became separated from 1251. OC1 25F(ab')2 gave highest tissue values of 1251, followed by cationic OC1 25F(ab')2 PIC; other species were much lower. The amounts of cee delivered per gram of tumour were much higher for cationic OC125F(ab')2 PIC than for other species. The results indicate that cationic charge stimulates the endocytosis and lysosomal degradation of the OC1 25F(ab')2-pl-cee that has bound to the i.p. tumour. Positively charged PICs may have applications in the i.p. photoimmunotherapy of minimal residual ovarian cancer.
Ovarian cancer ranks as the fifth most common malignancy in American women. In this country, approximately 1 in 70 women will develop ovarian cancer in their lifetime, and 1 in 100 will die of the disease (Parker et al, 1996) . It currently has the highest fatality to case ratio of all the gynaecological malignancies, primarily because most patients present with late-stage disease.
Overall 5-year survival for ovarian cancer is only 38%. Chemotherapy is the most frequently used adjunctive treatment following surgical debulking. Despite advances in chemotherapeutic regimens (Ozols, 1995) , there has been little or no change in the 5-year survival over the past 10 years.
Photodynamic therapy (PDT) is being considered as a useful weapon in the cancer therapy armament (Fisher et al, 1995; Hasan and Parrish, 1996) . It involves the systemic or intraperitoneal (i.p.) administration of a non-toxic drug called a photosensitizer (PS), which to some extent preferentially localizes in the tumour (Henderson and Dougherty, 1992) . When the tumour is irradiated with the wavelength of light that is absorbed by the PS, and in the presence of oxygen, toxic oxygen species are produced, which can cause tissue necrosis by a combination of mechanisms (including vascular shutdown, direct tumour cell killing and immune stimulation). PDT could be an attractive approach to eliminating the minimal residual disease after surgical debulking of ovarian cancer (DeLaney et al, 1993; Molpus et al, 1996a ). Because of the wide i.p. dissemination of the disease, the irradiation must be over a large area of the intraperitoneal surface, including intestines and other abdominal organs (Veenhuizen et al, 1994) . For this reason, it is important to investigate ways of increasing the specificity of the photosensitizer for the tumour, in order to spare damage to the normal tissues within the peritoneal cavity (Veenhuizen et al, 1994) .
One way to improve tumour specificity of photosensitizers is to link them covalently with tumour-targeting monoclonal antibodies (Hasan, 1992; Yarmush et al, 1993) . OC125 is a murine monoclonal antibody that recognizes the cell-surface antigen CA 125, a 1000-kDa glycoprotein (Hosono et al, 1992) expressed by 85% of non-mucinous epithelial ovarian cancers (Karlan et al, 1988) . Conjugates of OC125 with radioisotopes (Haisma et al, 1988; Muto et al, 1992) and cytotoxic drugs (Beck et al, 1994) have been administered i.p. to target ovarian cancer in both animals and humans. We have previously reported on the preparation (Goff et al, 1992) , in vitro reactions (Goff et al, 1991) and in vivo biodistribution ) of a conjugate between ce6 ethylenediamine monoamide (a derivative of ce6) and intact OC125, which had a negative charge owing to the use of a polyglutamic acid linker. Although the data on the reactions of this PIC with cell lines in vitro and with cells derived from tumour tissue ex vivo were encouraging, it gave only modest tumour to normal ratios and tumour uptake in vivo. As part of our ongoing effort to optimize the tumour selectivity and the uptake of PS delivered by PICs, this study has investigated the effect of charge modification of PICs derived from the F(ab')2 fragment of OC125 on their biodistribution in a new xenograft model of ovarian cancer. Because the effect of charge on the i.p. biodistribution of immunoconjugates is unknown, and because the use of F(ab')2 fragments shows advantages over intact IgG molecules in terms of penetration into tissue (Buchegger et al, 1990) , we have developed a new conjugation strategy applicable to F(ab')2 fragments and in which the charge can be either positive or negative. The PICs bearing either polycationic or polyanionic charges were prepared, labelled with 1251 and injected i.p. into a murine model derived a human ovarian carcinoma cell line (NIH:OVCAR-5). Biodistribution of both the protein moiety and the photosensitizer moiety were measured independently via tissue content of 1251 radioactivity and ce6 fluorescence respectively.
MATERIALS AND METHODS Mice
Female Swiss nude mice (Cox Breeding Laboratories, Cambridge, MA, USA) 6-8 weeks old received proper care and maintenance according to institutional guidelines. They had continuous access to food and water, which was taken ad libitum. Throughout the experiments mice were housed in laminar flow racks under specific pathogen-free conditions and were monitored daily for general health status. 
Antibodies
Monoclonal antibody OC125 F(ab')2 was a kind gift from Centacor (Malvem, PA, USA) and rabbit IgG was purchased from Sigma (St Louis, MO, USA). Both proteins were radiolabelled with 1251I by the lodogen procedure (Salacinski et al, 1981) . The specific activity of the OC125F(ab')2 was 8.7 MBq mg-', while that of the rabbit IgG was 2.1 MBq mg-'.
Conjugation procedure
The procedure has been described in detail elsewhere (Hamblin et al, 1996) . Briefly, poly-L-lysine (average mol. wt. 25 000) was treated in dimethyl sulphoxide (DMSO) with the N-hydroxysuccinimide ester of ce6 to give pl-ce6' This was then reacted with pyridyldithiopropionic acid N-hydroxysuccinimide ester to form the functionalized derivative pl-ce6-SPDP. This was then split into two parts and one part was treated with an excess of succinic anhydride to give the negatively charged functionalized pl-ce6-succ-SPDP.
[125I]OC125F(ab')2 or 1251-labelled rabbit IgG was reduced for 1 h with 5 mm mercaptoethylamine hydrochloride, dialysed and then reacted with either pl-ce6-SPDP or pl-ce6-succ-SPDP to form the cationic and anionic PICs respectively. When p1-ce6 was treated with succinic anhydride, pl-ce6-succ was obtained. The conjugates were purified by chromatography on Sephadex G200 columns and characterized by absorption and fluorescence spectrophotometry, and by polyacrylamide gel electrophoresis. The structures of the cationic PIC OC125F(ab')2-p1-ce6 and the anionic PIC OC125F(ab')2-pl-cg6-succ are shown in ELISAs OVCAR-5 cells were grown in a 96-well plate (10 000 cells ml-') to which was added RPMI containing 5% FCS. Cells were fixed with 0.025% glutaraldehyde, washed three times with PBS and blocked with 1% FCS, 1% glycine and 0.02% sodium azide. The MAb, conjugate or control mouse IgG was serially diluted from 0.1 mg ml-' to 10 ng ml' in PBS and 0.1 ml of protein solution was added and allowed to incubate for 2 h at room temperature. The MAb was removed and the fixed cells washed three times with PBS containing 0.05% Tween 20. To each well was added 0.1 ml of F(ab')2 fragment horseradish peroxidase-conjugated rabbit anti-mouse IgG (Zymed) diluted 1:400 in PBS containing 0.05% bovine serum albumin (BSA) and 0.05% Tween 20. This was allowed to incubate for 2 h, removed, washed three times with PBS/0.05% Tween 20 and 0.1 ml of a freshly prepared solution of 1,2-phenylenediamine (0.4 mg ml-') in 0. Animal model of ovarian cancer This has been described in detail elsewhere (Molpus et al, 1996b bound to 135 jig of protein), non-radioactive pl-ce6, pl-cee6-succ and free ce6 (10 jg of ce6 equivalent), all in 1 ml of sterile PBS.
Six mice in each group were sacrificed using inhalation anaesthesia at 3-h and 24-h intervals. Two tumour nodules (one from the pelvis and one from the abdomen) and samples of normal tissues OC1 25F(ab')2 3 5.7 ± 2.3 2.3 ± 0.2 3.5 ± 0.7 2.1 ± 0.6 1.9 ± 0.3 5.4 ± 2.1 3.5 ± 0.4 30.1 ± 1.3 OC1 25F(ab')2 24 2.7 ± 0.6 2.8 ± 0.2 5.4 ± 0.5 3.0± 1.2 1.4 ± 0.2 4.0± 1.7 3.2 ± 0.4 38.1 ± 2.9 OC1 25F(ab')2-Pl-c,6 3 5.4 ± 1.2 0.9 ± 0.1 6.4 ± 1.2 3.3 ± 0.8 4.7 ± 2.5 10.6 ± 5.2 5.2 ± 1.0 25.8 ± 6.5 OC1 25F(ab' )2-PI-c,6 24 4.2 ± 2.5 1.5 ± 1.0 2.9 ± 1.4 3.6 ± 3.0 2.6 ± 1.5 3.3 ± 1.1 3.0 ± 0.4 17.1 ± 1.8 OC1 25F(ab')2-pI-c,6-succ 3 4.9 ± 1.7 3.6 ± 1.8 3.5 ± 0.9 2.4 ± 0.5 2.4 ± 0.6 2.7 ± 0.5 3.3 ± 0.4 6.3 ± 1.3.
OC1 25F(ab')2-pI-ce6-succ 24 2.8 ± 0.9 2.4 ± 1.0 7.1 ± 1.7 1.9 ± 0.7 3.0 ± 1.0 6.0 ± 0.9 3.9 ± 0.7 3.8 ± 0.9
Rabbit IgG 3 2.7 ± 0.7 1.5 ± 0.5 2.6 ± 0.7 0.7 ± 0.2 1.8 ± 0.5 2.6 ± 1.0 1.8 ± 0. Rabbit IgG-pl-cw6-succ 3 2.7 ± 0.6 1.5 ± 0.4 3.9 ± 0.7 0.9 ± 0.2 2.1 ± 0.5 2.8 ± 0.7 1.5 + 0.1 6.7 ± 2.3
Rabbit IgG-pl-c96-succ 24 1.5 ± 0.3 1.0 ± 0.4 1.5 ± 0.2 0.7 ± 0.1 0.8 ± 0.2 1.4 ± 0.2 0.9 + 0.1 3. 
Animal model
The predominant clinical manifestation is diffuse, macroscopic intraperitoneal disease. Tumour deposits cover all serosal surfaces especially pelvis, subgastrium and peritoneum. Widespread carcinomatosis preceded any significant ascites production. Owing to the extensive presence of macroscopic and microscopic tumour, it proved impossible to dissect areas of normal peritoneum to evaluate the uptake of the MAbs and PICs by normal peritoneum.
Tumour: normal tissue ratios of 1251
These are shown for six normal organs and for the means of the ratios for all six organs in Table 1 . Also given for comparison are the values for %ID 1251 per g of tumour. Unmodified OC125F(ab')2 and rabbit IgG are compared with cationic and anionic PICs prepared from these proteins. The mean ratios obtained with OC125F(ab')2 and its cationic and anionic PICs are significantly greater (two to four times) than the corresponding mean ratios obtained with the equivalent rabbit IgG conjugate and time after injection (P < 0.01 in each of six cases). At 3 h, the mean ratio for cationic OCl25F(ab')2-pl-ce6 (5.2 ± 1.0) was significantly greater than that for unmodified OC125F(ab')2 at 3 h (3.5 ± 0.4, P < 0.05) and at 24 h (3.2 ± 0.4,P < 0.05) and anionic OC125F(ab')2-pl-c,6-succ at 3 h (3.3 ± 0.4, P < 0.05) but not at 24 h. However, this ratio obtained with the cationic OC125F(ab')2-pl-ce6 fell sharply at 24 h (3.0 ± 0.4, P < 0.05). The mean ratios for 1251 delivered by rabbit IgG (both unmodified protein and PICs) were found to be significantly higher at 3 h than at 24 h (P < 0.05 for all three forms). In addition, at 3 h the mean ratio from the cationic rabbit IgG PIC (2.2 ± 0.25) was significantly higher than the anionic rabbit IgG PIC (1.47 ± 0. 1, P < 0.01), but not the unmodified rabbit IgG. The main difference in organ distribution was the low tumour -kidney ratio when the i25J was delivered by the cationic OC125F(ab')2-plce6, which was significantly lower than that from unmodified OC125F(ab')2 (P < 0.001) and from anionic OC125F(ab')2-pl-ce6-succ (P < 0.05) at 3 h.
Percentage injected dose per gram of 1251 from OC125F(ab')2 and rabbit IgG PICs I25l uptake expressed as the percentage injected dose per gram of tissue into six normal organs and the mean of two tumour samples, delivered by unmodified OC125F(ab')2 and cationic and anionic OC125F(ab')2 PICs after 3 h is shown in Figure 3A and after 24 h in Figure 3B . It can be seen that the amount of 1251 retained not only in tumour but also in normal organs is highest for unmodified OC125F(ab')2, lower for the cationic OC125F(ab')2 PIC and lowest for the anionic OC125F(ab')2 PIC at both time points. Figure 4A and B shows the percentage injected dose per gram for i251 delivered by rabbit IgG and its conjugates. The overall values are significantly lower than those found for the OC125F(ab')2 and, in addition to the values for tumour being lower, the values for skin are higher.
British Journal of Cancer (1997) 75(6) (Weagle et al, 1988 ) that mice fed on laboratory chow containing chlorophyll have varying amounts of a chlorin-like metabolite in their gastrointestinal tract and sometimes in their skin. In agreement with these results, we found chlorin-like fluorescence emission spectra in tissue extracts from the intestines and skin of non-injected mice. These values were variable and generally lower than that delivered to these organs by i.p. injected ce6 derivatives, and the mean values of endogenous fluorescence peak areas per gram of tissue from nine control mice were subtracted from the peak areas per gram of skin and intestine tissue in the mice injected with ce6 conjugates.
Tumour-normal tissue ratios of c06
The tumour to normal tissue ratios of c content measured for four normal organs (liver, kidney, intestines and skin) and the means of these four ratios, removed at 3-h and 24-h intervals after i.p. injection, are shown in Table 2 . Also given for comparison are the absolute fluorescence content for the tumour in peak area per gram. These are given for ce6 delivered by the cationic and anionic charged forms of OC125F(ab')2 PIC, rabbit IgG PIC, polylysine conjugates and free ce6. Values are not given for the tumour to normal ratios of spleen and lung, as the amount of fluorescence extracted from these tissues was so low that the ratios would have been unreasonably high (from 100-10 000). The mean of the tumour: normal ratios at 3 h obtained from the cationic OC125F(ab')2 PlC (18.7 ± 4.5) was significantly higher than that from the anionic OC125F(ab')2PIC (7.7 ± 2.6, P < 0.05), significantly higher than cationic pl-ce6 (10.0 ± 2.0, P < 0.05), but not different from cationic rabbit IgG-pl-ce6. At 24 h, the ratio from the cationic OC125F(ab')2 PlC (23.1 ± 8.1) was not significantly different from the anionic OC125(ab')2 PIC (18.6 ± 5.8) or from the cationic rabbit IgG-pl-ce6 (30.4 ± 8.4), but was significantly higher than cationic pl-ce6 (3.6 + 1.6, P < 0.01). The mean ratio from the anionic OC125F(ab')2PIC at 24 h (18.6 ± 5.8) was significantly greater than that found from the same PIC at 3 h (7.7 ± 2.6, P < 0.05), but neither at 3 h nor 24 h did the anionic OC1 25F(ab')2 PIC give significantly higher tumour to normal ratios than the anionic rabbit IgG PIC or the anionic pl-ce6-succ. It should be noted that one of the most sensitive normal structures to i.p. PDT is the intestines (Veenhuizen et al, 1994) . In this case, the tumour to intestine ratios for the cationic OC125F(ab')2 PIC at 3 h (9.7 ± 3.4) and the anionic OC125F(ab')2 PIC at 24 h (4.0 ± 1.3) were significantly greater than the tumour to intestines ratios of all species at all time points (P < 0.05) except the anionic rabbit IgG PIC at 24 h (2.2 ± 1.5).
Relative amount of c. delivered to tumour by OC125F(ab')2 and rabbit IgG PICs
Although the tumour to normal ratios obtained with ce6 delivered by OC125F(ab')2 PICs were not significantly higher than those found with rabbit IgG PICs for either charge or time point, there may still be an advantage in using OC125F(ab')2 PICs, if they deliver a higher amount of the PS to the tumour. That this is indeed so for the cationic conjugates is shown in Figure 5 . The uptake from the OC125F(ab')2 cationic PIC was 3.2 times greater at 3 h and 3.8 times greater at 24 h than that from the rabbit IgG cationic PIC (P < 0.05 in both cases). The uptake of ce6 delivered by the cationic OC125F(ab')2 PIC was also 7.6 times and 2.5 times higher than that from the anionic OC125F(ab')2 PIC at 3 h and 24 h respectively (P < 0.05 in both cases). Aside from the cationic OC125F(ab')2 PIG, other species did not give significant differences except for the anionic OC125F(ab')2 PIC, which at 24 h delivered 33 times more than anionic pl-ce6-succ (P < 0.01).
DISCUSSION
Conjugation procedures may, in addition to sometimes reducing the affinity and or the specificity of the MAb for the antigen, produce structural changes so profound that the fundamental biochemical trafficking of the MAb is changed. This change may be either for the better or for the worse, as far as targeting the cytotoxic moiety to the tumour is concerned. The present study has investigated the biodistribution of OC125F(ab')2 PICs of opposite charge after i.p. administration in an i.p. xenograft model of ovarian cancer in nude mice. The biodistribution of 1251-labelled protein was measured independently from the PS ce6. There are three biodistribution parameters that may affect the efficacy of i.p. PDT. These are (1) the maximum concentration of the PS in the tumour; (2) the maximum tumour -normal tissue ratio of PS with respect to the most sensitive normal structure (thought to be the intestines; (Veenhuizen et al, 1994) ; and (3) the maximum penetration depth of the PS into the tumour nodules. This study has not addressed point (3) at all, and has gained preliminary data on parameters (1) and (2) with two opposite charged PICs and two time points after administration.
The cationic OC125F(ab')2 PIC has a marked advantage in delivering a higher amount of ce6 to the tumour than the anionic PIC, especially at 3 h. In addition, the cationic OC125F(ab')2 PIC delivers more ce6 (2.5-80 times) than any other species at both time points. The cationic rabbit PIC also produces tumour-normal tissue ratios that are remarkably similar to those produced by the cationic OC125F(ab')2 PIC at both time points, but the absolute amount of ce6 delivered to the tumour was 3.2 and 3.8 times higher for the cationic OC125F(ab')2 PIC at 3 h and 24 h respectively. The cationic OC125F(ab')2 PIC is also the only delivery vehicle, which gives sizeable tumour to intestine ratios of ce6. It is thought (Veenhuizen et al, 1994) (Ryser et al, 1982) . Molecules that are internalized into cells by virtue of their positive charge undergo endosomal processing (Hansen et al, 1993) and accumulate in lysosomes, where proteolysis may take place. Pardridge et al (1994a,b) have compared unmodified and cationic monoclonal antibodies and found much increased endocytosis of the cationic species. In vivo, it has been shown that cationized IgG molecules have a much higher organ take-up than the unmodified form (Triguero et al, 1991) .
By comparing the results gained from the ce6 and 1251 measurements, it is possible to gain insights into the extent to which the MAb is responsible for the tumour targeting, and what is happening to the constituent parts of the PIC. The data show a marked separation of the ce6 from the 1251. The ce6 is much more likely to stay in the tissues directly exposed to peritoneal fluid, while the 1251 is more likely to travel to distant organs via the bloodstream or the lymphatics. The extremely low levels of ce6 found in the lungs and spleen indicate that very little ce6 reaches the bloodstream compared with 1251. There are three possible ways in which this separation could happen. Firstly, PICs could be endocytosed into lysosomes and proteolysed to small peptides and amino acids, which could then leave the cells and enter the circulation. This has been demonstrated to occur in vitro (Press et al, 1988) and is thought to be the most likely mechanism in vivo (Press et al, 1990) . Secondly, the 1251 could be removed from the protein by a deiodinating activity (Smith et al, , 1994 , and the free iodide ion could diffuse rapidly throughout the circulation. Thirdly, the pl-ce6 and pl-c 6-succ are attached to the OC125F(ab')2 via a nonhindered disulphide bond that has been shown to be susceptible to in vivo reduction (Carroll et al, 1994) . This would separate the ce6 from the 1251 but would leave the latter still in the OC125F(ab')2, which might then be expected to give higher tumour to normal ratios of 1251 than ce6, which is the opposite of what is found. If the cationic conjugates are taken up by i.p. tumour cells via endocytosis and degraded in lysosomes where the 1251 was released and the ce6 retained, this would explain the higher tumour to normal ratios of ce6 compared with 1251, and would also be consistent with in vitro data using these OC125F(ab)2 PICs (Hamblin et al, 1996) and previous work using conjugates between'251 labelled low-density lipoprotein and haematoporphyrin (Hamblin and Newman, 1994) . The high ratios but low absolute content of ce6 found for the cationic and anionic rabbit IgG PICs are also consistent with this hypothesis. However, it must be stated that the rabbit IgG PICs were formed from an intact IgG not a F(ab')2 fragment, and this may lead to different pharmacokinetic parameters. The in vivo metabolism of the PICs could be confirmed by carrying out experiments that looked at the degree to which ce6 and 1251 in various tissue extracts could be precipitated by trichloroacetic acid.
The mean values of percentage injected dose 125I per gram of tissue for six normal organs and two tumour samples are shown in Figure 6 . It is apparent that there are significant differences between PICs in the extent to which 1251 is taken up into organs.
Unmodified OC125F(ab')2 has an uptake that is twice as high (P < 0.01) as cationic OC125F(ab')2 PIC at both time points, while this uptake in turn is three times (P < 0.005) higher than that from the anionic OC 125F(ab')2 PIC. These differences are not apparent with the uptake from the rabbit IgG PICs, which seem to deliver the same percentages of injected dose to tissues regardless of the charge on the PIC. There is therefore some difference between the unmodified OC125F(ab')2 PIC and rabbit IgG that causes the former to be taken up into tissue much more and, in addition, makes variation in the charge of OC125F(ab')2 affect the degree to which it is taken up into tissue. This difference may either be the fact of antibody antigen recognition or the fact that the MAb is a F(ab')2 fragment, while the rabbit is an entire IgG molecule. If the cationic OC125F(ab')2 PIC is endocytosed and subject to lysosomal hydrolysis, this explains the higher uptake of ce6 (compared with the anionic) by the tumour, the higher tissue uptake of 1251 and also the higher uptake of 125I by the kidneys (without concomitant ce6), as proteolytic fragments and amino acids are small enough to be excreted by glomerular filtration . The high tissue uptake of the unmodified OC125F(ab')2, however, may not be by endocytosis and hydrolysis, but by transcytosis across the mesothelial barrier of the peritoneum (Flessner and Dedrick, 1994) or via diaphragmatic lymphatics (Abernethy et al, 1991) into the circulation and hence to tumour and other organs. The low uptake of anionic OC125F(ab')2 is presumably explained by the negative charge inhibiting the uptake found with unmodified OC125F(ab')2, and not stimulating endocytosis as seen with the cationic PIC.
The fact that the tumour-normal ratios of 125I are higher for the OC125F(ab')2 of both charges than they are for the equivalent rabbit IgG PICs while the ratios of ce6 are similar, can be explained if one assumes that a PIC that binds to a cell owing to MAb antigen attraction is less likely to be internalized than the same PIC that binds via charge interaction. Then a greater proportion of the cationic rabbit IgG PIC that can only bind via charge will be internalized, degraded and the 1251 lost from the tumour tissue than is found for the cationic OC125F(ab')2-pl-ce6
The mean tumour-normal (blood, liver, kidney, intestine and spleen) ratios found in the study by Thedrez et al (1989) using "'Inlabelled intact OC 125 injected i.p. into nude mice bearing OVCAR-3 tumours were higher than those found at similar time points with our ['25I]OC125F(ab')2 (at 3 h 6.0 ± 1.4 vs 3.5 ± 0.4 and at 24 h 6.9 ± 2.7 vs 3.2 ± 0.4 respectively). The reasons for this difference may be the decreased metabolism of "'In-labelled MAbs, the use of intact IgG or the use of OVCAR-3 cells, which express more CA125 than OVCAR-5 cells. However, the tumour to normal ratio of 125I obtained by the cationic PIC at 3 h (5.2 ± 1.0) is similar to the value found with the IIIIn-labelled MAb (6.0 ± 1.4).
In summary, this initial biodistribution study demonstrates a distinct advantage of administering PICs with a positive charge to i.p. xenograft model of ovarian cancer. For example, the mean tumour -normal (blood, liver, kidney, skin and intestine) ratios reported by Goff et al (1994) for the PS (CMA) delivered by intact OC125-PGA-CMA were at 6.8 ± 1.4 at 3h and 5.9 ± 0.7 at 24 h, which are much lower than those found in the present case (18.7 + 4.5 and 23.1 ± 8.1 respectively). For comparison, ratios found with non-conjugated PS using HpD injected i.p. into mice bearing i.p. teratoma (Tochner et al, 1986) were 9.3 ± 1.4 at 2 h and 2.4 ± 1.0 at 24 h (tumour: liver, kidney, intestine and muscle), and, using the present model and i.p. injected liposomal benzoporphyrin derivative (Molpus et al, 1996a ), 1.4 ± 0.4 at 2 h and 2.1 ± 1.0 at 24 h (tumour -liver, kidney, skin, intestine, peritoneum and spleen). The tumoricidal efficiency of the ce6 will be determined by, among other factors, whether the photochemistry of ce6 has been affected by the conjugation, and on the macroscopic and microscopic site(s) of localization of the PICs. These questions are under investigation in our laboratory.
